Off-label Uses for Biologics
Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
Christopher Bunick, MD, PhD
The Little Ones: Perspectives on Pediatric Psoriasis and AD
Top 2023 Psoriasis Treatment Announcements
Daniel I. Schlessinger, MD
PsA-5T-Ds: A New Psoriatic Arthritis Assessment Tool
Philip Mease, MD
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying PracticalDermatology…but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.